Amprenavir

Description	Like all HIV protease inhibitors, amprenavir interrupts the maturation phase of the HIV replicative cycle by forming an inhibitor-enzyme complex, which prevents HIV protease from binding with its normal substrates. It has an enzyme inhibition constant (Ki = 0.6 nM) that falls within the Ki range of the other protease inhibitors.
Pathways	Protease/Metabolic Enzyme Microbiology/Virology
Targets	HIV Protease HIV

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.